Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT06424834
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 150 participants
- Registry
-
NCT06424834
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06424834. Randomized; quadruple masking; primary purpose treatment. Start 2024-10-10 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
- Acronym
- MVP-ANOCA
- Condition
- Angina Pectoris
- Condition
- Microvascular Angina
- Condition
- Vasospastic Angina
- Condition
- Myocardial Bridge of Coronary Artery
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Nebivolol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Stanford University
- Collaborator
- American Heart Association
Record details
- Record id
cardio:ct-nct06424834- Content hash
318ffceb3ce92d2cff893239218dab7cc4ba9045e6ba781030ea7e0cf5233d80